Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for clinical and paraclinical symptoms in polycystic ovary syndrome
IRCT20220720055510N1Phase 2Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of liraglutide in polycystic ovary syndrome (PCOS), sponsored by Shahrekord University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20220720055510N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220720055510N1.